Look for:

Our offer for

Research Detail

2023/09/08 / Erste Group Research

Healthcare sector with +12% earnings growth in 2024e

Rating changes: SAP, Banco Santander, Novartis, ConocoPhillips, S&P Global, Nike, Taiwan Semiconductor, AstraZeneca, Amadeus IT Group, Moncler

As the 2Q23 reporting season draws to a close, investor focus is increasingly turning to 2024 earnings expectations, where growth is forecast to accelerate in both revenue and earnings. Calculated in USD, sales growth should accelerate to +3.7% y/y (23e: +0.6%). The earnings forecast for the world's 1000 largest stocks has also improved slightly recently. In the coming year, the expected increase is +8.5% y/y (23e: +4.2%).

In the healthcare sector, which we continue to favor, earnings growth of +12% Y/Y is forecast for 2024. The expected growth rate is thus significantly above that of the overall market. Novartis convinces us by the recently implemented business policy measures and due to an attractive valuation.

SAP: Further revenue growth potential through AI integration in applications

S&P Global: Leading financial services provider increases free cash flow very strongly this year

PDF Download Download PDF (8.5MB)

General information

AuthorErste Group Research
Product nameRecommendation List
Topic in focusEquities
Economy in focusGermany, Japan, United States
Currency in focusEuro, US Dollar
Sector in focusAutomobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities